vs
Side-by-side financial comparison of AMERICAN AXLE & MANUFACTURING HOLDINGS INC (AXL) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.
BeOne Medicines Ltd. is the larger business by last-quarter revenue ($1.5B vs $1.4B, roughly 1.1× AMERICAN AXLE & MANUFACTURING HOLDINGS INC). BeOne Medicines Ltd. runs the higher net margin — 4.4% vs -5.4%, a 9.9% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs 0.2%). BeOne Medicines Ltd. produced more free cash flow last quarter ($379.8M vs $54.7M). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs -7.2%).
American Axle & Manufacturing, Inc. (AAM), headquartered in Detroit, Michigan, is an American manufacturer of automobile driveline and drivetrain components and systems.
BeOne Medicines Ltd.ONCEarnings & Financial Report
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
AXL vs ONC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.4B | $1.5B |
| Net Profit | $-75.3M | $66.5M |
| Gross Margin | 10.2% | 90.5% |
| Operating Margin | -2.4% | 12.4% |
| Net Margin | -5.4% | 4.4% |
| Revenue YoY | 0.2% | 32.8% |
| Net Profit YoY | -449.6% | 143.8% |
| EPS (diluted) | $-0.62 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.4B | $1.5B | ||
| Q3 25 | $1.5B | $1.4B | ||
| Q2 25 | $1.5B | $1.3B | ||
| Q1 25 | $1.4B | $1.1B | ||
| Q4 24 | $1.4B | $1.1B | ||
| Q3 24 | $1.5B | $1.0B | ||
| Q2 24 | $1.6B | $929.2M | ||
| Q1 24 | $1.6B | $751.7M |
| Q4 25 | $-75.3M | $66.5M | ||
| Q3 25 | $9.2M | $124.8M | ||
| Q2 25 | $39.3M | $94.3M | ||
| Q1 25 | $7.1M | $1.3M | ||
| Q4 24 | $-13.7M | $-151.9M | ||
| Q3 24 | $10.0M | $-121.3M | ||
| Q2 24 | $18.2M | $-120.4M | ||
| Q1 24 | $20.5M | $-251.2M |
| Q4 25 | 10.2% | 90.5% | ||
| Q3 25 | 12.6% | 86.1% | ||
| Q2 25 | 13.1% | 87.5% | ||
| Q1 25 | 12.3% | 85.2% | ||
| Q4 24 | 11.2% | 85.8% | ||
| Q3 24 | 11.4% | 83.0% | ||
| Q2 24 | 13.3% | 85.1% | ||
| Q1 24 | 12.4% | 83.4% |
| Q4 25 | -2.4% | 12.4% | ||
| Q3 25 | 3.2% | 11.5% | ||
| Q2 25 | 3.6% | 6.7% | ||
| Q1 25 | 3.0% | 1.0% | ||
| Q4 24 | 2.6% | -7.0% | ||
| Q3 24 | 2.8% | -12.0% | ||
| Q2 24 | 5.3% | -11.5% | ||
| Q1 24 | 4.8% | -34.8% |
| Q4 25 | -5.4% | 4.4% | ||
| Q3 25 | 0.6% | 8.8% | ||
| Q2 25 | 2.6% | 7.2% | ||
| Q1 25 | 0.5% | 0.1% | ||
| Q4 24 | -1.0% | -13.5% | ||
| Q3 24 | 0.7% | -12.1% | ||
| Q2 24 | 1.1% | -13.0% | ||
| Q1 24 | 1.3% | -33.4% |
| Q4 25 | $-0.62 | $0.05 | ||
| Q3 25 | $0.07 | $0.08 | ||
| Q2 25 | $0.32 | $0.06 | ||
| Q1 25 | $0.06 | $0.00 | ||
| Q4 24 | $-0.11 | $-0.10 | ||
| Q3 24 | $0.08 | $-0.09 | ||
| Q2 24 | $0.15 | $-0.09 | ||
| Q1 24 | $0.17 | $-0.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $708.9M | $4.5B |
| Total DebtLower is stronger | $4.0B | $836.4M |
| Stockholders' EquityBook value | $640.0M | $4.4B |
| Total Assets | $6.7B | $8.2B |
| Debt / EquityLower = less leverage | 6.31× | 0.19× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $708.9M | $4.5B | ||
| Q3 25 | $714.1M | $4.0B | ||
| Q2 25 | $586.5M | $2.8B | ||
| Q1 25 | $549.2M | $2.5B | ||
| Q4 24 | $552.9M | $2.6B | ||
| Q3 24 | $542.5M | $2.7B | ||
| Q2 24 | $519.9M | $2.6B | ||
| Q1 24 | $469.8M | $2.8B |
| Q4 25 | $4.0B | $836.4M | ||
| Q3 25 | $2.6B | — | ||
| Q2 25 | $2.6B | — | ||
| Q1 25 | $2.6B | — | ||
| Q4 24 | $2.6B | — | ||
| Q3 24 | $2.6B | — | ||
| Q2 24 | $2.7B | — | ||
| Q1 24 | $2.7B | — |
| Q4 25 | $640.0M | $4.4B | ||
| Q3 25 | $718.4M | $4.1B | ||
| Q2 25 | $673.0M | $3.8B | ||
| Q1 25 | $596.3M | $3.5B | ||
| Q4 24 | $562.8M | $3.3B | ||
| Q3 24 | $616.3M | $3.4B | ||
| Q2 24 | $609.6M | $3.4B | ||
| Q1 24 | $621.4M | $3.4B |
| Q4 25 | $6.7B | $8.2B | ||
| Q3 25 | $5.3B | $7.6B | ||
| Q2 25 | $5.3B | $6.3B | ||
| Q1 25 | $5.1B | $5.8B | ||
| Q4 24 | $5.1B | $5.9B | ||
| Q3 24 | $5.3B | $5.8B | ||
| Q2 24 | $5.3B | $5.7B | ||
| Q1 24 | $5.4B | $5.7B |
| Q4 25 | 6.31× | 0.19× | ||
| Q3 25 | 3.61× | — | ||
| Q2 25 | 3.86× | — | ||
| Q1 25 | 4.38× | — | ||
| Q4 24 | 4.58× | — | ||
| Q3 24 | 4.28× | — | ||
| Q2 24 | 4.42× | — | ||
| Q1 24 | 4.40× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $120.5M | $417.3M |
| Free Cash FlowOCF − Capex | $54.7M | $379.8M |
| FCF MarginFCF / Revenue | 4.0% | 25.4% |
| Capex IntensityCapex / Revenue | 4.8% | 2.5% |
| Cash ConversionOCF / Net Profit | — | 6.28× |
| TTM Free Cash FlowTrailing 4 quarters | $155.1M | $941.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $120.5M | $417.3M | ||
| Q3 25 | $143.3M | $402.6M | ||
| Q2 25 | $91.9M | $263.6M | ||
| Q1 25 | $55.9M | $44.1M | ||
| Q4 24 | $151.2M | $75.2M | ||
| Q3 24 | $143.6M | $188.4M | ||
| Q2 24 | $142.8M | $-95.6M | ||
| Q1 24 | $17.8M | $-308.6M |
| Q4 25 | $54.7M | $379.8M | ||
| Q3 25 | $79.2M | $354.5M | ||
| Q2 25 | $34.6M | $219.8M | ||
| Q1 25 | $-13.4M | $-12.3M | ||
| Q4 24 | $73.2M | $-17.3M | ||
| Q3 24 | $70.4M | $54.7M | ||
| Q2 24 | $94.0M | $-205.5M | ||
| Q1 24 | $-30.2M | $-465.1M |
| Q4 25 | 4.0% | 25.4% | ||
| Q3 25 | 5.3% | 25.1% | ||
| Q2 25 | 2.3% | 16.7% | ||
| Q1 25 | -0.9% | -1.1% | ||
| Q4 24 | 5.3% | -1.5% | ||
| Q3 24 | 4.7% | 5.5% | ||
| Q2 24 | 5.8% | -22.1% | ||
| Q1 24 | -1.9% | -61.9% |
| Q4 25 | 4.8% | 2.5% | ||
| Q3 25 | 4.3% | 3.4% | ||
| Q2 25 | 3.7% | 3.3% | ||
| Q1 25 | 4.9% | 5.0% | ||
| Q4 24 | 5.6% | 8.2% | ||
| Q3 24 | 4.9% | 13.3% | ||
| Q2 24 | 3.0% | 11.8% | ||
| Q1 24 | 3.0% | 20.8% |
| Q4 25 | — | 6.28× | ||
| Q3 25 | 15.58× | 3.22× | ||
| Q2 25 | 2.34× | 2.79× | ||
| Q1 25 | 7.87× | 34.71× | ||
| Q4 24 | — | — | ||
| Q3 24 | 14.36× | — | ||
| Q2 24 | 7.85× | — | ||
| Q1 24 | 0.87× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AXL
| Driveline | $748.4M | 54% |
| Other | $345.7M | 25% |
| Metal Forming | $289.8M | 21% |
ONC
Segment breakdown not available.
